Science Explorer Back to mapMap
Institution · Tenovus Cancer Care

Most cited papers from Tenovus Cancer Care

What are the most cited papers from Tenovus Cancer Care?

The most cited paper from Tenovus Cancer Care is "Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)" (Daniel J. Klionsky et al., 2016), with 6,023 citations. Next come "EGFR and cancer prognosis" (2,166) and "Guidelines for the welfare and use of animals in cancer research" (1,468).

Showing 50 of 61 papers. Every paper with more than 223 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J. Klionsky et al. · Autophagy Open access2,467 authors 2 Jan 2016 6,023
2 EGFR and cancer prognosis Robert I. Nicholson, Julia M.W. Gee, M. E. Harper · European Journal of Cancer Sep 2001 2,166
3 Guidelines for the welfare and use of animals in cancer research Paul Workman, Eric Ofori Aboagye, Frances R. Balkwill et al. · British Journal of Cancer Open access May 2010 1,468
4 A prognostic index in primary breast cancer J. L. Haybittle, R.W. Blamey, C.W. Elston et al. · British Journal of Cancer Open access Mar 1982 718
5 Ectopic lymphoid-like structures in infection, cancer and autoimmunity Costantino Pitzalis, Gareth Wyn Jones, Michele Bombardieri et al. · Nature reviews. Immunology Review 20 Jun 2014 707
6 Immunostimulatory monoclonal antibodies for cancer therapy Ignacio Melero, Sandra Hervás‐Stubbs, Martin J. Glennie et al. · Nature reviews. Cancer Review 24 Jan 2007 635
7 The Biological Activity of Human CD20 Monoclonal Antibodies Is Linked to Unique Epitopes on CD20 Jessica L. Teeling, Wendy J.M. Mackus, Luus Wiegman et al. · The Journal of Immunology Open access Jul 2006 610
8 Expression of luminal and basal cytokeratins in human breast carcinoma Dalia M. Abd El‐Rehim, Sarah E. Pinder, Claire E. Paish et al. · The Journal of Pathology 14 Apr 2004 601
9 Viral infection switches non-plasmacytoid dendritic cells into high interferon producers Sandra S. Diebold, María Montoya, Hermann Unger et al. · Nature 22 Jun 2003 580
10 Genetic content of wild-type human cytomegalovirus Aidan Dolan, Charles Cunningham, Ralph D. Hector et al. · Journal of General Virology Open access 22 Apr 2004 575
11 Elevated Levels of Epidermal Growth Factor Receptor/c-erbB2 Heterodimers Mediate an Autocrine Growth Regulatory Pathway in Tamoxifen-Resistant MCF-7 Cells Janice M. Knowlden, Iain R. Hutcheson, Helen E. Jones et al. · Endocrinology 13 Feb 2003 537
12 Mechanisms of killing by anti-CD20 monoclonal antibodies Martin J. Glennie, Ruth R. French, Mark Steven Cragg et al. · Molecular Immunology Sep 2007 516
13 Maternity blues and major endocrine changes: Cardiff puerperal mood and hormone study II Benjamin L. Harris, Lisetta M. Lovett, Robert Gordon Newcombe et al. · BMJ Open access 9 Apr 1994 491
14 Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase Erika Mariana Palmieri, Marieli Gonzalez-Cotto, Walter Allen Baseler et al. · Nature Communications Open access 4 Feb 2020 474
15 Quantitative Temporal Viromics: An Approach to Investigate Host-Pathogen Interaction Michael P. Weekes, Peter Tomašec, Edward L. Huttlin et al. · Cell Open access Jun 2014 459
16 Steroids in Saliva for Assessing Endocrine Function D Riad-Fahmy, G F Read, Richard F. Walker et al. · Endocrine Reviews Oct 1982 432
17 CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help Ruth R. French, H.T. Claude Chan, Alison L. Tutt et al. · Nature Medicine May 1999 432
18 Dietary flour supplementation decreases post-menopausal hot flushes: Effect of soy and wheat Alice L. Murkies, C. F. Lombard, Boyd J. Strauss et al. · Maturitas Apr 1995 420
19 Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action Charles Kent Osborne, A. E. Wakeling, Robert I. Nicholson · British Journal of Cancer Open access Mar 2004 414
20 Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival Jennifer H. Law, Golareh Habibi, Kaiji Hu et al. · Cancer Research Open access 15 Dec 2008 412
21 Tumour-elicited neutrophils engage mitochondrial metabolism to circumvent nutrient limitations and maintain immune suppression Christopher M. Rice, Luke C. Davies, Jeffrey J. Subleski et al. · Nature Communications Open access 26 Nov 2018 374
22 The Biology of CD20 and Its Potential as a Target for mAb Therapy Mark Steven Cragg, Claire A. Walshe, Andrey O. Ivanov et al. · Current directions in autoimmunity Book chapter 2004 365
23 Comparison of the Effects of a Pure Steroidal antiestrogen With Those of Tamoxifen in a Model of Human Breast Cancer C. Kent Osborne, Ester Coronado-Heinsohn, S. G. Hilsenbeck et al. · JNCI Journal of the National Cancer Institute 17 May 1995 364
24 Antibody specificity controls in vivo effector mechanisms of anti-CD20 reagents Mark Steven Cragg, Martin J. Glennie · Blood 14 Oct 2003 361
25 A full genome scan for late onset Alzheimer's disease Patrick G. Kehoe · Human Molecular Genetics Feb 1999 358
26 Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection Stephen A. Beers, Ruth R. French, H.T. Claude Chan et al. · Blood 11 Mar 2010 336
27 The role of sleep in pain and fibromyalgia Ernest Choy · Nature Reviews Rheumatology Review 24 Apr 2015 334
28 Regulation of ERBB2 by oestrogen receptor–PAX2 determines response to tamoxifen Antoni Hurtado, Kelly A. Holmes, Timothy R. Geistlinger et al. · Nature Open access 12 Nov 2008 324
29 Increased Complement Biosynthesis By Microglia and Complement Activation on Neurons in Huntington's Disease Sim K. Singhrao, James William Neal, B. Paul Morgan et al. · Experimental Neurology Oct 1999 319
30 Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia Stuart Lanham, Terry John Hamblin, David Graham Oscier et al. · Blood 15 Jan 2003 314
31 A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease Jenny A. Orchard, Richard Garand, Zadie A. Davis et al. · Blood 4 Mar 2003 301
32 Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells Helen E. Jones, Lindy Goddard, Julia M.W. Gee et al. · Endocrine Related Cancer Open access Dec 2004 298
33 Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignancies Waleed Alduaij, Andrei Ivanov, Jamie Honeychurch et al. · Blood Open access 4 Mar 2011 295
34 DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma CATHERINE A. KING, Myfanwy Bailey Spellerberg, Delin Zhu et al. · Nature Medicine Nov 1998 295
35 Clinical trials of antibody therapy Martin J. Glennie, Peter W.M Johnson · Immunology Today Aug 2000 288
36 The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation Paul J. Lehner, Jaana T. Karttunen, Gavin W. G. Wilkinson et al. · Proceedings of the National Academy of Sciences Open access 24 Jun 1997 285
37 Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication Richard James Stanton, Katarina Baluchova, Derrick J. Dargan et al. · Journal of Clinical Investigation Open access 3 Aug 2010 280
38 Cognitive behavioural therapies for fibromyalgia Kathrin Bernardy, Petra Klose, Angela J Busch et al. · Cochrane Database of Systematic Reviews Open access 10 Sep 2013 275
39 Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells Stephen Hiscox, Liam D. Morgan, Tim P. Green et al. · Breast Cancer Research and Treatment 6 Dec 2005 274
40 Downregulation of natural killer cell–activating ligand CD155 by human cytomegalovirus UL141 Peter Tomašec, Eddie C. Y. Wang, Andrew J. Davison et al. · Nature Immunology Open access 9 Jan 2005 273
41 Synovial tissue research: a state-of-the-art review Carl Kieran Orr et al. · Nature Reviews Rheumatology ReviewOpen access 13 Jul 2017 266
42 Fc gamma receptor IIb on target B cells promotes rituximab internalization and reduces clinical efficacy Sean H. Lim, Andrew T. Vaughan, Margaret Ashton‐Key et al. · Blood Open access 19 Jul 2011 266
43 Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of β-catenin phosphorylation Stephen Hiscox, Wen G. Jiang, Kathrin Obermeier et al. · International Journal of Cancer 3 Aug 2005 265
44 Ki67 immunostaining in primary breast cancer: pathological and clinical associations N Bouzubar, K. M. Walker, K. Griffiths et al. · British Journal of Cancer Open access Jun 1989 262
45 The LZT proteins; the LIV-1 subfamily of zinc transporters KM Taylor, Robert I. Nicholson · Biochimica et Biophysica Acta (BBA) - Biomembranes Open access Apr 2003 259
46 Invasive lobular carcinoma of the breast: Response to hormonal therapy and outcomes Emad A. Rakha, Maysa E. El‐Sayed, Desmond George Powe et al. · European Journal of Cancer Dec 2007 259
47 Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer Julia M.W. Gee, John F.R. Robertson, Ian Ogilvie Ellis et al. · International Journal of Cancer 2001 259
48 Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma Dalia M. Abd El‐Rehim, Sarah E. Pinder, Claire E. Paish et al. · British Journal of Cancer Open access Oct 2004 256
49 Anti-CD20 monoclonal antibodies: historical and future perspectives Sean H. Lim, Stephen A. Beers, Ruth R. French et al. · Haematologica Open access 22 Sep 2009 245
50 Modulation of natural killer cells by human cytomegalovirus Gavin W. G. Wilkinson, Peter Tomašec, Richard James Stanton et al. · Journal of Clinical Virology Open access 20 Feb 2008 244

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.